Nur 660 Final 2024-2025 Newest!!! Actual Complete Exam

NUR 660 FINAL 2024-2025 NEWEST!!! ACTUAL COMPLETE EXAM QUESTIONS AND CORRECT ANSWERS (VERIFIED ANSWERS) ALREADY GRADED A+. The effects of GLP-1 Agonist medications include all of the following EXCEPT: Select one: a. glucagon induced gluconeogenesis b. increased satiety c. improved glycemic control d. glucose dependent insulin secretion - ANSWER-glucagon induced gluconeogenesis A common adverse effect with SGLT-2 Inhibitors is: Select one: a. edema b. mycotic infection c. hypertension d. weight gain - ANSWER-Mycotic Infection Due to the increased risk for hypoglycemia, the following two medication classes should not be used in combination: Select one: a. insulin and metformin b. insulin and sulfonylurea c. insulin and thiazolidinedione d. insulin and acarbose - ANSWER-Insulin and SulfonylureaA patient is 66 inches in height, weighing 200 lbs, and newly diagnosed with type 2 diabetes mellitus (DM). The A1c is 7.1%. What is the best initial treatment? Select one: a. Diet, exercise, and metformin b. No treatment at this time c. Diet and exercise d. Diet, exercise, and exogenous insulin - ANSWER-Diet and exercise, Diet, exercise, and metformin Which medication is an insulin secretagogue (mechanism of action is to secrete insulin)? Select one: a. acarbose (alpha-glucosidase inhibitor) b. empagliflozin (SGLT2 Inhibitor) c. rosiglitazone (thiazolidinedione) d.